Literature DB >> 25088362

HYPONYCHIUM ABNORMALITIES Congenital Aberrant Hyponychium vs. Acquired Pterygium Inversum Unguis vs. Acquired Reversible Extended Hyponychium: a proposed classification based on origin, pathology and outcome.

N Zaias1, S X Escovar1, M N Zaiac2, E Del Rio1, N Dou1, C Ricotti3, L Karai3, M Florez-White2.   

Abstract

BACKGROUND: Pterygium Inversum Unguis (PIU) is a wing-like extended hyponychium associated with the absence of the distal groove. Although a rare condition, it has been described with different names, confusing both the investigator and the reader.
OBJECTIVE: We propose a new nomenclature based on tissue origin and pathology, to account for these conditions. 1) Congenital Aberrant Hyponychium 2) Acquired Pterygium Inversum Unguis 3) Acquired Reversible Extended Hyponychium. MAIN OBSERVATIONS: We report a case of a 19-year-old male, with epidermal pigmentation abnormalities, who had painful fingertips of both index fingers and thumbs since he was 13. He therefore let his finger nails grow very long, minimizing painful contact with the hyponychium. Removal of the aberrant hyponychium revealed glomus bodies aggregates with increased nerve fibers. Subsequently after excision of the hyponychium, his pain was resolved.
SUMMARY: Congenital, transient or permanent changes in the hyponychium should be named and classified according to tissue origin to avoid nomenclature confusion.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2014        PMID: 25088362     DOI: 10.1111/jdv.12632

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

Review 1.  The Diagnosis and Treatment of Nail Disorders.

Authors:  Uwe Wollina; Pietro Nenoff; Gunter Haroske; Holger A Haenssle
Journal:  Dtsch Arztebl Int       Date:  2016-07-25       Impact factor: 5.594

2.  Onychophagia Induced Melanonychia, Splinter Hemorrhages, Leukonychia, and Pterygium Inversum Unguis Concurrently.

Authors:  Sezin Fıçıcıoğlu; Selma Korkmaz
Journal:  Case Rep Dermatol Med       Date:  2018-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.